Charles Schwab’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $711K | Sell |
273,472
-24,408
| -8% | -$63.5K | ﹤0.01% | 3010 |
|
|
2025
Q1 | $566K | Buy |
297,880
+11,689
| +4% | +$22.2K | ﹤0.01% | 3039 |
|
|
2024
Q4 | $415K | Hold |
286,191
| – | – | ﹤0.01% | 3194 |
|
|
2024
Q3 | $527K | Hold |
286,191
| – | – | ﹤0.01% | 3139 |
|
|
2024
Q2 | $286K | Buy |
286,191
+45,996
| +19% | +$46K | ﹤0.01% | 3377 |
|
|
2024
Q1 | $476K | Sell |
240,195
-5,817
| -2% | -$11.5K | ﹤0.01% | 3044 |
|
|
2023
Q4 | $384K | Sell |
246,012
-17,264
| -7% | -$26.9K | ﹤0.01% | 3166 |
|
|
2023
Q3 | $519K | Buy |
263,276
+11,880
| +5% | +$23.4K | ﹤0.01% | 3024 |
|
|
2023
Q2 | $799K | Buy |
251,396
+208,629
| +488% | +$663K | ﹤0.01% | 2841 |
|
|
2023
Q1 | $140K | Hold |
42,767
| – | – | ﹤0.01% | 3209 |
|
|
2022
Q4 | $215K | Buy |
42,767
+11,031
| +35% | +$55.5K | ﹤0.01% | 3173 |
|
|
2022
Q3 | $73K | Buy |
+31,736
| New | +$73K | ﹤0.01% | 3251 |
|